Biocon And Juno Partner On Liraglutide In Canada

Cites Potential Addressable Canadian Market Of Around $100m For Diabetes Treatment

 
• By David Wallace
  
Canadian flags
Biocon and Juno have agreed an alliance on liraglutide in Canada • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Deals

More from Business